Content of stem tumor CD133⁺ cells in brain neoplasms of different histological type

Today, there are conflicting data on the content of cancer stem cells responsible for recurrence and resistance to chemotherapy in tumors of human brain. The aim of the study was to analyze the content of CD133⁺cells in different brain tumors by immunofluorescence assay and immunohistochemical metho...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2017
Автори: Lisyaniy, N.I., Stanetskaya, D.N., Lisyaniy, A.N., Belskaya, L.N.
Формат: Стаття
Мова:English
Опубліковано: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2017
Назва видання:Experimental Oncology
Теми:
Онлайн доступ:http://dspace.nbuv.gov.ua/handle/123456789/138544
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Цитувати:Content of stem tumor CD133⁺ cells in brain neoplasms of different histological type / N.I. Lisyaniy, D.N. Stanetskaya, A.N. Lisyaniy, L.N. Belskaya // Experimental Oncology. — 2017 — Т. 39, № 3. — С. 219–223. — Бібліогр.: 26 назв. — англ.

Репозитарії

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id irk-123456789-138544
record_format dspace
spelling irk-123456789-1385442018-06-20T03:04:25Z Content of stem tumor CD133⁺ cells in brain neoplasms of different histological type Lisyaniy, N.I. Stanetskaya, D.N. Lisyaniy, A.N. Belskaya, L.N. Original contributions Today, there are conflicting data on the content of cancer stem cells responsible for recurrence and resistance to chemotherapy in tumors of human brain. The aim of the study was to analyze the content of CD133⁺cells in different brain tumors by immunofluorescence assay and immunohistochemical method. Materials and Methods: The samples of different brain tumors removed during neurosurgical operations were studied for CD133 expression. Results: Immunofluorescence assay of tumor imprints revealed CD133⁺cells in 40–85% of tumors regardless of histological type. In malignant tumors, the count of CD133⁺cells was higher than in benign tumors. Immunohistochemical method used for detection of CD133⁺cells was less sensitive than immunofluorescence technique. The number of CD133⁺cells may vary even in tumors of the same histological type. In 20–30% of malignant tumors (glioblastomas, medulloblastomas), the content of CD133⁺cells was very low or not detected at all. Conclusions: In tumors of the brain of different genesis and degree of anaplasia CD133⁺cells are found out. In malignant tumors (glioblastomas and medulloblastomas), CD133⁺cells are much more frequently detected than in benign brain tumors. The content of CD133⁺cells in brain tumors is highly variable being small and some malignant tumors, indicating low predictive and diagnostic value of cancer stem cell content in clinical practice. 2017 Article Content of stem tumor CD133⁺ cells in brain neoplasms of different histological type / N.I. Lisyaniy, D.N. Stanetskaya, A.N. Lisyaniy, L.N. Belskaya // Experimental Oncology. — 2017 — Т. 39, № 3. — С. 219–223. — Бібліогр.: 26 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/138544 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
language English
topic Original contributions
Original contributions
spellingShingle Original contributions
Original contributions
Lisyaniy, N.I.
Stanetskaya, D.N.
Lisyaniy, A.N.
Belskaya, L.N.
Content of stem tumor CD133⁺ cells in brain neoplasms of different histological type
Experimental Oncology
description Today, there are conflicting data on the content of cancer stem cells responsible for recurrence and resistance to chemotherapy in tumors of human brain. The aim of the study was to analyze the content of CD133⁺cells in different brain tumors by immunofluorescence assay and immunohistochemical method. Materials and Methods: The samples of different brain tumors removed during neurosurgical operations were studied for CD133 expression. Results: Immunofluorescence assay of tumor imprints revealed CD133⁺cells in 40–85% of tumors regardless of histological type. In malignant tumors, the count of CD133⁺cells was higher than in benign tumors. Immunohistochemical method used for detection of CD133⁺cells was less sensitive than immunofluorescence technique. The number of CD133⁺cells may vary even in tumors of the same histological type. In 20–30% of malignant tumors (glioblastomas, medulloblastomas), the content of CD133⁺cells was very low or not detected at all. Conclusions: In tumors of the brain of different genesis and degree of anaplasia CD133⁺cells are found out. In malignant tumors (glioblastomas and medulloblastomas), CD133⁺cells are much more frequently detected than in benign brain tumors. The content of CD133⁺cells in brain tumors is highly variable being small and some malignant tumors, indicating low predictive and diagnostic value of cancer stem cell content in clinical practice.
format Article
author Lisyaniy, N.I.
Stanetskaya, D.N.
Lisyaniy, A.N.
Belskaya, L.N.
author_facet Lisyaniy, N.I.
Stanetskaya, D.N.
Lisyaniy, A.N.
Belskaya, L.N.
author_sort Lisyaniy, N.I.
title Content of stem tumor CD133⁺ cells in brain neoplasms of different histological type
title_short Content of stem tumor CD133⁺ cells in brain neoplasms of different histological type
title_full Content of stem tumor CD133⁺ cells in brain neoplasms of different histological type
title_fullStr Content of stem tumor CD133⁺ cells in brain neoplasms of different histological type
title_full_unstemmed Content of stem tumor CD133⁺ cells in brain neoplasms of different histological type
title_sort content of stem tumor cd133⁺ cells in brain neoplasms of different histological type
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
publishDate 2017
topic_facet Original contributions
url http://dspace.nbuv.gov.ua/handle/123456789/138544
citation_txt Content of stem tumor CD133⁺ cells in brain neoplasms of different histological type / N.I. Lisyaniy, D.N. Stanetskaya, A.N. Lisyaniy, L.N. Belskaya // Experimental Oncology. — 2017 — Т. 39, № 3. — С. 219–223. — Бібліогр.: 26 назв. — англ.
series Experimental Oncology
work_keys_str_mv AT lisyaniyni contentofstemtumorcd133cellsinbrainneoplasmsofdifferenthistologicaltype
AT stanetskayadn contentofstemtumorcd133cellsinbrainneoplasmsofdifferenthistologicaltype
AT lisyaniyan contentofstemtumorcd133cellsinbrainneoplasmsofdifferenthistologicaltype
AT belskayaln contentofstemtumorcd133cellsinbrainneoplasmsofdifferenthistologicaltype
first_indexed 2023-10-18T21:18:06Z
last_indexed 2023-10-18T21:18:06Z
_version_ 1796152449868759040